FIELD: biotechnology.
SUBSTANCE: method is proposed for determining the sequence of nucleotide types in a nucleic acid comprising the steps of DNA sequencing and preparation of granules with luminescent markers.
EFFECT: invention can be used for sequencing, separation, detection and identification of objects and biological molecules for laboratory-diagnostic purposes.
3 cl, 16 dwg, 10 ex
| Title | Year | Author | Number |
|---|---|---|---|
| IDENTIFICATION OF POLYNUCLEOTIDES ASSOCIATED WITH SAMPLE | 2012 |
|
RU2644681C2 |
| GENOMIC SELECTION AND SEQUENCING USING CODED MICROCARRIERS | 2010 |
|
RU2609630C2 |
| LARGE-SCALE MONOCELLULAR TRANSCRIPTOME LIBRARIES AND METHODS FOR THEIR PRODUCTION AND USE | 2019 |
|
RU2773318C2 |
| KIT FOR SYNTHESIS REACTION MIXTURE SYNTHESIS 3′-O-PROPARGYL-MODIFIED NUCLEIC ACID | 2014 |
|
RU2688435C2 |
| DIAGNOSING AND TREATING BREAST CANCER | 2011 |
|
RU2550925C2 |
| HIGH-THROUGHPUT SINGLE CELL SEQUENCING WITH REDUCED AMPLIFICATION ERROR | 2019 |
|
RU2833615C2 |
| SYSTEMS AND METHODS FOR APPLICATION OF TRANSCRIPTION SEQUENCING DEPENDENT ON ROTATION | 2012 |
|
RU2636460C2 |
| METHOD AND COMPOSITION FOR ANALYSIS OF CELLULAR COMPONENTS | 2016 |
|
RU2761432C2 |
| METHODS FOR PREDICTING RISK OF INTERSTITIAL PNEUMONIA | 2014 |
|
RU2670148C2 |
| PLATFORM FOR DETECTING AND ANALYZING THERAPEUTIC AGENTS | 2016 |
|
RU2724998C2 |
